CRISPR Therapeutics AG (CRSP) › Net IncomeCRISPR Therapeutics AG (CRSP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$7.01M2015: -$25.50M2016: -$23.18M2017: -$68.36M2018: -$164.98M2019: $66.86M2020: -$348.87M2021: $377.66M2022: -$650.17M2023: -$153.61M2024: -$366.25M2025: -$581.60M-$581.60M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$581.60M-58.8%2024-$366.25M-138.4%2023-$153.61M+76.4%2022-$650.17M-272.2%2021$377.66M+208.3%2020-$348.87M-621.8%2019$66.86M+140.5%2018-$164.98M-141.4%2017-$68.36M-194.9%2016-$23.18M+9.1%2015-$25.50M-263.9%2014-$7.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share